• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Implementing U.S. Covid-19 Testing: Regulatory and Infrastructural Challenges.

作者信息

Tan Yongtian Tina, Kesselheim Aaron S

机构信息

Yongtian Tina Tan, M.D., M.B.A., is is a third year pediatric resident at University of California San Francisco and a recent graduate of the Harvard M.D./M.B.A. program. Aaron S. Kesselheim, M.D., J.D., M.P.H., is Professor of Medicine at Harvard Medical School, a faculty member of the Division of Pharmacoepidemiology and Pharmacoeconomics in the Department of Medicine at Brigham and Women's Hospital, the Director of the Program on Regulation, Therapeutics, and Law (PORTAL), and a primary care physician. He is the Editor-in-Chief of the Journal of Law, Medicine & Ethics.

出版信息

J Law Med Ethics. 2020 Sep;48(3):606-612. doi: 10.1177/1073110520958889.

DOI:10.1177/1073110520958889
PMID:33021179
Abstract
摘要

相似文献

1
Implementing U.S. Covid-19 Testing: Regulatory and Infrastructural Challenges.美国新冠病毒检测的实施:监管与基础设施挑战
J Law Med Ethics. 2020 Sep;48(3):606-612. doi: 10.1177/1073110520958889.
2
Diagnostic Testing for the Novel Coronavirus.新型冠状病毒的诊断检测
JAMA. 2020 Apr 21;323(15):1437-1438. doi: 10.1001/jama.2020.3864.
3
Failing the Test - The Tragic Data Gap Undermining the U.S. Pandemic Response.测试失败——削弱美国疫情应对的悲剧性数据缺口。
N Engl J Med. 2020 Jul 23;383(4):299-302. doi: 10.1056/NEJMp2014836. Epub 2020 May 15.
4
SARS-CoV-2 diagnostic testing in Africa: needs and challenges.非洲的新型冠状病毒肺炎诊断检测:需求与挑战
Pan Afr Med J. 2020 Apr 14;35(Suppl 2):4. doi: 10.11604/pamj.2020.35.4.22703. eCollection 2020.
5
[COVID-19 and Pulmonology: New Challenges and Opportunities].[新型冠状病毒肺炎与肺病学:新挑战与新机遇]
Acta Med Port. 2020 Oct 1;33(10):710. doi: 10.20344/amp.14760. Epub 2020 Sep 2.
6
[Sensitivity, specificity, predictive values in serological Covid-19 tests].[新冠病毒病血清学检测中的敏感性、特异性及预测值]
Epidemiol Prev. 2020 Mar-Jun;44(2-3):189-190. doi: 10.19191/EP20.2-3.P189.042.
7
Reopening Society and the Need for Real-Time Assessment of COVID-19 at the Community Level.重新开放社会与社区层面新冠病毒病实时评估的必要性
JAMA. 2020 Jun 9;323(22):2247-2248. doi: 10.1001/jama.2020.7872.
8
Evolving reporting criteria of COVID-19 in Taiwan during the epidemic.台湾地区新冠疫情期间不断演变的新冠病毒疾病报告标准。
J Microbiol Immunol Infect. 2020 Jun;53(3):413-418. doi: 10.1016/j.jmii.2020.03.014. Epub 2020 Mar 19.
9
Thousands of coronavirus tests are going unused in US labs.美国实验室里有成千上万份冠状病毒检测试剂无人使用。
Nature. 2020 Apr;580(7803):312-313. doi: 10.1038/d41586-020-01068-3.
10
Covid-19 Molecular Diagnostic Testing - Lessons Learned.新冠病毒-19分子诊断检测——经验教训
N Engl J Med. 2020 Oct 22;383(17):e97. doi: 10.1056/NEJMp2023830. Epub 2020 Sep 9.